Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.110
-0.040 (-3.48%)
At close: Feb 21, 2025, 4:00 PM
1.120
+0.010 (0.91%)
After-hours: Feb 21, 2025, 4:13 PM EST
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $8.60 million as of February 21, 2025. Its market cap has increased by 274.41% in one year.
Market Cap
8.60M
Enterprise Value
6.71M
1-Year Change
274.41%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $8.60M, a decrease of -75.62%. That is a compound annual growth rate of -34.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 8.60M | 1.83% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |